Red blood cell (RBC) transfusion rates among US chronic dialysis patients during changes to Medicare end-stage renal disease (ESRD) reimbursement systems and erythropoiesis stimulating agent (ESA) labels
Crossref DOI link: https://doi.org/10.1186/1471-2369-15-116
Published Online: 2014-07-11
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cappell, Katherine A
Shreay, Sanatan
Cao, Zhun
Varker, Helen V
Paoli, Carly J
Gitlin, Matthew
License valid from 2014-07-11
Article History
Received: 12 September 2013
Accepted: 30 June 2014
First Online: 11 July 2014